GlassScriptPhysician profile
Ashkan Shahkarami
NPI 1821226994
$8,588.00
in general payments reported to CMS, 2019-2025
15 companies · $1,576 in 2025
The $1,576 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.23 · 2020: $47.58 · 2021: $865 · 2022: $2,088 · 2023: $2,436 · 2024: $1,538 · 2025: $1,576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,789 · Food and Beverage: $2,227 · Travel and Lodging: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,789.33 |
| Food and Beverage | $2,227.33 |
| Travel and Lodging | $533.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $3,707.77 | 2021-2025 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Inari Medical, INC. | $1,991.50 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sirtex Medical INC | $1,215.06 | 2019-2022 | |
| Boston Scientific Corporation | $673.35 | 2022-2025 | Ekosonic, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), General - Embolics |
| Medtronic, INC. | $361.17 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Bard Peripheral Vascular, INC. | $220.67 | 2023-2025 | Venovo, Venclose Maven Catheter, Lutonix Drug Coated Balloon |
| Stryker Corporation | $179.55 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Venclose INC. | $62.28 | 2019-2020 | |
| Relievant Medsystems, INC. | $51.68 | 2023 | Intracept |
| Penumbra, INC. | $30.17 | 2021-2024 | Indigo System |
| Terumo Medical Corporation | $25.16 | 2024 | Azur Cx Detachable |
| Abbott Laboratories | $21.11 | 2023 | Proclaim |
| Chiesi USA, INC. | $18.48 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.35 | 2021 | |
| Argon Medical Devices, INC. | $14.70 | 2024 | Clot Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashkan Shahkarami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.